Affiner les résultats

Systemtherapie des kolorektalen Karzinoms = Systemic therapy for colorectal cancer

Pestalozzi, B. ; Jäger, D. ; Knuth, A.

Selective Intra-arterial Chemotherapy with Floxuridine as Second- or Third-Line Approach in Patients with Unresectable Colorectal Liver Metastases

Samaras, Panagiotis ; Breitenstein, S. ; Haile, S. ; Stenner-Liewen, F. ; Heinrich, S. ; Feilchenfeldt, J. ; Renner, C. ; Knuth, A. ; Pestalozzi, B. ; Clavien, P.

In: Annals of Surgical Oncology, 2011, vol. 18, no. 7, p. 1924-1931

The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours: long-term outcome of treatment with imatinib mesylate

Goerres, G. ; Stupp, R. ; Barghouth, G. ; Hany, T. ; Pestalozzi, B. ; Dizendorf, E. ; Schnyder, P. ; Luthi, F. ; von Schulthess, G. ; Leyvraz, S.

In: European Journal of Nuclear Medicine and Molecular Imaging, 2005, vol. 32, no. 2, p. 153-162

Molekular zielgerichtete Therapie = Molecular targeted therapy

Stenner-Liewen, F. ; Zippelius, A. ; Pestalozzi, B. ; Knuth, A.

Primary breast cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Pestalozzi, B. ; Castiglione, M.

In: Annals of Oncology, 2008, vol. 19, p. ii7-ii10

Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK

Borner, M. ; Koeberle, D. ; Von Moos, R. ; Saletti, P. ; Rauch, D. ; Hess, V. ; Trojan, A. ; Helbling, D. ; Pestalozzi, B. ; Caspar, C. ; Ruhstaller, T. ; Roth, A. ; Kappeler, A. ; Dietrich, D. ; Lanz, D. ; Mingrone, W.

In: Annals of Oncology, 2008, vol. 19, no. 7, p. 1288-1292

Combining gemcitabine, oxaliplatin and capecitabine (GEMOXEL) for patients with advanced pancreatic carcinoma (APC): a phase I/II trial

Hess, V. ; Pratsch, S. ; Potthast, S. ; Lee, L. ; Winterhalder, R. ; Widmer, L. ; Cescato, C. ; Lohri, A. ; Jost, L. ; Stillhart, P. ; Pestalozzi, B. ; Herrmann, R.

In: Annals of Oncology, 2010, vol. 21, no. 12, p. 2390-2395

Addition of cetuximab to first-line chemotherapy in patients with advanced non-small-cell lung cancer: a cost-utility analysis

Joerger, M. ; Matter-Walstra, K. ; Früh, M. ; Kühnel, U. ; Szucs, T. ; Pestalozzi, B. ; Schwenkglenks, M.

In: Annals of Oncology, 2011, vol. 22, no. 3, p. 567-574

The impact of adding low-dose leucovorin to monthly 5-fluorouracil in advanced colorectal carcinoma: Results of a phase III trial

Borner, M. M. ; Castiglione, M. ; Bacchi, M. ; Weber, W. ; Herrmann, R. ; Fey, M. F. ; Pagani, O. ; Leyvraz, S. ; Morant, R. ; Pestalozzi, B. ; Hanselmann, S. ; Goldhirsch, A.

In: Annals of Oncology, 1998, vol. 9, no. 5, p. 535-541